Learn More
Medchemexpress LLC Thalidomide-NH-CBP/p300 ligand 2 | 2484739-21-9 | 98.6% | C48H57F2N11O6 | 10MG

Supplier: Medchemexpress LLC HY13970710MG
Thalidomide-NH-CBP/p300 ligand 2 is a thalidomide-based PROTAC small molecule designed to induce proteasomal degradation of the transcriptional coactivators CBP and p300. It couples a thalidomide-derived E3 ligase recruiting moiety to a CBP/p300-binding ligand and is provided as a light yellow solid for research use.
- Induces proteasomal degradation of CBP and p300.
- Employs a thalidomide-derived E3 ligase recruiting moiety.
- Designed for use in cellular and mechanistic research applications.
- High purity suitable for research (reported ~98.6%).
- Provided as a light yellow solid with molecular weight ~922.03 g·mol⁻¹.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.